Historical Review and Cost-Effectiveness Assessment of the Programs to Eliminate Onchocerciasis and Trachoma in Mexico

Choosing Timing and Boundary for Futility Analysis Based on Cost-Effectiveness Assessment

Statistics in Biopharmaceutical Research ◽

10.1080/19466315.2018.1456483 ◽

2018 ◽

Vol 10 (2) ◽

pp. 104-111 ◽

Cited By ~ 1

Author(s):

Qiqi Deng ◽

Xiaoqi Lu

Keyword(s):

Cost Effectiveness ◽

The growth of cost-effectiveness assessment in environmental health legislation

Journal of the Royal Society of Health ◽

10.1177/146642409611600504 ◽

1996 ◽

Vol 116 (5) ◽

pp. 287-289

Author(s):

T. Smalley

Keyword(s):

Cost Effectiveness ◽

Environmental Health ◽

Health Legislation ◽

PCN20 COST-EFFECTIVENESS ASSESSMENT FOR COLOMBIA OF LETROZOLE VS. TAMOXIFEN IN ADJUVANT TREATMENT OF HORMONE RECEPTOR-POSITIVE, POST-MENOPAUSAL EARLY BREAST CANCER WOMEN

Value in Health ◽

10.1016/s1098-3015(10)75347-x ◽

2009 ◽

Vol 12 (7) ◽

pp. A496

Author(s):

O Gamboa ◽

L Chicaiza ◽

M Garcia

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Hormone Receptor ◽

Hormone Receptor Positive ◽

Post Menopausal ◽

PP62. Cost/effectiveness assessment of cytogenetic and molecular biology analysis for acute leukemia's prognosis

European Journal of Cancer ◽

10.1016/s0959-8049(97)85975-8 ◽

1997 ◽

Vol 33 ◽

pp. S37

Author(s):

G Tonnaire ◽

J Gabert ◽

M Lafage ◽

D Sainty ◽

D Maraninchi ◽

...

Keyword(s):

Cost Effectiveness ◽

Molecular Biology ◽

Cost-effectiveness Assessment of Commonly-used Drugs for Hepatoprotection and Enzymes Reduction Based on Decision Tree and Multi-utility Theory

Chinese Herbal Medicines ◽

10.1016/s1674-6384(14)60046-0 ◽

2014 ◽

Vol 6 (4) ◽

pp. 305-312

Author(s):

Jia-qi Xu ◽

Rui-fang Xie ◽

Zhi-cheng Li ◽

Jing-yi Tang ◽

Xin Zhou

Keyword(s):

Cost Effectiveness ◽

Decision Tree ◽

Utility Theory ◽

Investigating Potential Problems in Comparator Drug Selection for Cost-Effectiveness Assessment of Newly Approved Drugs for Reimbursement Decision

The Journal of Health Technology Assessment ◽

10.34161/johta.2017.5.1.008 ◽

2017 ◽

Vol 5 (1) ◽

pp. 59-65

Author(s):

Lee, Hankil ◽

강혜영 ◽

조현석

Keyword(s):

Cost Effectiveness ◽

Reimbursement Decision ◽

Drug Selection ◽

Potential Problems ◽

Selection For ◽

Approved Drugs ◽

Comparator Drug ◽

Enhancements to angioplasty for peripheral arterial occlusive disease: systematic review, cost-effectiveness assessment and expected value of information analysis

Health Technology Assessment ◽

10.3310/hta18100 ◽

2014 ◽

Vol 18 (10) ◽

Cited By ~ 14

Author(s):

Emma L Simpson ◽

Benjamin Kearns ◽

Matthew D Stevenson ◽

Anna J Cantrell ◽

Chris Littlewood ◽

...

Keyword(s):

Systematic Review ◽

Cost Effectiveness ◽

Peripheral Arterial Occlusive Disease ◽

Value Of Information ◽

Arterial Occlusive Disease ◽

Information Analysis ◽

Expected Value Of Information ◽

Peripheral Arterial ◽

Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh

Vaccine ◽

10.1016/j.vaccine.2021.09.044 ◽

2021 ◽

Vol 39 (43) ◽

pp. 6356-6363

Author(s):

Wu Zeng ◽

Yujie Cui ◽

Eva Jarawan ◽

Carlos Avila ◽

Guohong Li ◽

...

Keyword(s):

Cost Effectiveness ◽

Vaccination Strategies ◽

Endemic Cholera ◽

Optifast® Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Assessment from the Employer Perspective in the USA

Value in Health ◽

10.1016/j.jval.2018.04.1708 ◽

2018 ◽

Vol 21 ◽

pp. S253

Author(s):

M Perugini ◽

AM Marczewska ◽

K Araujo Torres ◽

B Rasouli ◽

M Nuijten

Keyword(s):

Cost Effectiveness ◽

Meal Replacement ◽

The Usa ◽

Employer Perspective ◽

Treatment Of Obesity ◽

Cost Effectiveness Assessment ◽

Meal Replacement Program

PMS71 A COST-EFFECTIVENESS ASSESSMENT OF ABATACEPT FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN HUNGARY

Value in Health ◽

10.1016/s1098-3015(10)66812-x ◽

2008 ◽

Vol 11 (6) ◽

pp. A549-A550

Author(s):

V Brodszky ◽

F Borgström ◽

S Arnetorp ◽

M Péntek ◽

L Gulácsi

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽